Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keoe
Lexington, Massachusetts, United Statesairnav.com ↗
- Ownership
- Private
- Employees
- ~169
- Development stage
- Other
01
Overview
Keros Therapeutics is advancing multiple clinical-stage assets targeting dysfunctional signaling of the transforming growth factor-beta family. Its lead program, elritercept, is in Phase III trials for transfusion-dependent anemia in MDS. Another candidate, cibotercept, was discontinued after safety concerns in PAH. Early-stage asset KER‑065 has shown promising tolerability and activity in neuromuscular disease models; a Phase II trial is planned for DMD pending regulatory feedback. The company recently entered into a major partnership with Takeda to develop elritercept globally except China regions.
- Therapeutic areas
- HematologyNeurologyCardiovascular
- Modalities
- ProteinSmall molecule
- Industry
- Biotech
02
Partnerships
Takeda (global development/commercialization deal excluding China regions)Hansoh Healthtech Co., Ltd. (China region licensing agreement)
Beyond the preview
Go deeper on Keoe.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Keoe.